COMPLETED

Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Maxillary nerve blocks have been shown to significantly reduce post-operative pain and analgesic intake during the 24-hour period following sinus surgery. This randomized, double-blinded, placebo-controlled study will investigate blocks of the pterygopalatine fossa using a suprazygomatic approach during septorhinoplasty surgery. It is the investigator's hypothesis that this technique will result in decreased post-operative pain and opioid use, and the morbidity associated with it.

Official Title

Post-operative Pain Control With Sphenopalantine Ganglion Nerve Block in Septorhinoplasty Patients

Quick Facts

Study Start:2023-04-12
Study Completion:2025-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05667324

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patient presenting for open or endoscopic septorhinoplasty
  2. * Age 18-80
  3. * Normal oral food and water intake before surgery
  4. * ASA physical classification 1-3
  1. * Refusal to consent
  2. * Patients without a cellular phone or who are unable to accept text messages
  3. * Allergy to opioid narcotics
  4. * ASA physical classification of 4 or higher
  5. * Patient requires other surgery in addition to septorhinoplasty
  6. * Age \> 80 or \<18
  7. * Any underlying chronic pain condition or ongoing opioid use over the preceding 3 months
  8. * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for block placement.
  9. * Presence of any other factor which, at the discretion of any member of the study team, makes the patient a poor candidate for research participation.
  10. * Pregnant women

Contacts and Locations

Principal Investigator

Jeffrey D Johnson, MD
PRINCIPAL_INVESTIGATOR
University of Florida

Study Locations (Sites)

UF Health of University of Florida
Gainesville, Florida, 32610
United States

Collaborators and Investigators

Sponsor: University of Florida

  • Jeffrey D Johnson, MD, PRINCIPAL_INVESTIGATOR, University of Florida

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-12
Study Completion Date2025-02-28

Study Record Updates

Study Start Date2023-04-12
Study Completion Date2025-02-28

Terms related to this study

Keywords Provided by Researchers

  • Post-op pain
  • septorhinoplasty
  • deviated septum

Additional Relevant MeSH Terms

  • Deviated Nasal Septum